Epirubicin loaded super paramagnetic iron oxide nanoparticle-aptamer bioconjugate for combined colon cancer therapy and imaging in vivo.

[1]  S. Hussain,et al.  Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging , 2001, European Radiology.

[2]  P. Gibbs,et al.  Overview of biomarkers in metastatic colorectal cancer: tumour, blood and patient-related factors. , 2013, Critical reviews in oncology/hematology.

[3]  Swati G. Patel,et al.  Familial Colon Cancer Syndromes: an Update of a Rapidly Evolving Field , 2012, Current Gastroenterology Reports.

[4]  Ching-Hsein Chen,et al.  GRP78 Knockdown Enhances Apoptosis via the Down-Regulation of Oxidative Stress and Akt Pathway after Epirubicin Treatment in Colon Cancer DLD-1 Cells , 2012, PloS one.

[5]  S. Christensen,et al.  Nanostructures for medical diagnostics , 2012 .

[6]  N. M. Noor,et al.  Participation and barriers to colorectal cancer screening in Malaysia. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[7]  Xin-guo Jiang,et al.  Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. , 2011, Biomaterials.

[8]  Mohammad Ramezani,et al.  Reversible targeting and controlled release delivery of daunorubicin to cancer cells by aptamer-wrapped carbon nanotubes. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[9]  P. Ray,et al.  Aptamers for Targeted Drug Delivery , 2010, Pharmaceuticals.

[10]  J. Behravan,et al.  Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer , 2010, Journal of drug targeting.

[11]  Xiaoquan Yang,et al.  Application of targeted drug delivery system in Chinese medicine. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[12]  X. Ye,et al.  Recent advances in biological strategies for targeted drug delivery. , 2009, Cardiovascular & hematological disorders drug targets.

[13]  Yi Lu,et al.  Reversible cell-specific drug delivery with aptamer-functionalized liposomes. , 2009, Angewandte Chemie.

[14]  Lin Zhu,et al.  Targeted delivery of methotrexate to skeletal muscular tissue by thermosensitive magnetoliposomes. , 2009, International journal of pharmaceutics.

[15]  Xiaoling Zhang,et al.  Molecular Assembly of an Aptamer–Drug Conjugate for Targeted Drug Delivery to Tumor Cells , 2009, Chembiochem : a European journal of chemical biology.

[16]  J. Gariépy,et al.  Phototoxic aptamers selectively enter and kill epithelial cancer cells , 2008, Nucleic acids research.

[17]  Robert Langer,et al.  Superparamagnetic Iron Oxide Nanoparticle-Aptamer Bioconjugates for Combined Prostate Cancer Imaging and Therapy , 2011 .

[18]  Robert Langer,et al.  Nanotechnology and Aptamers: Applications in Drug Delivery , 2022 .

[19]  Sangjin Park,et al.  Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo. , 2008, Angewandte Chemie.

[20]  R. Stoltenburg,et al.  SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands. , 2007, Biomolecular engineering.

[21]  Sangjin Park,et al.  Thermally cross-linked superparamagnetic iron oxide nanoparticles: synthesis and application as a dual imaging probe for cancer in vivo. , 2007, Journal of the American Chemical Society.

[22]  S. Duan,et al.  Mapping genes that contribute to daunorubicin-induced cytotoxicity. , 2007, Cancer research.

[23]  Lisa Brannon-Peppas,et al.  Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation. , 2007, Nanomedicine.

[24]  B. Sullenger,et al.  Gene therapy progress and prospects: RNA aptamers , 2007, Gene Therapy.

[25]  Robert Langer,et al.  An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform. , 2006, Angewandte Chemie.

[26]  R. Weissleder.  Molecular Imaging in Cancer , 2006, Science.

[27]  D. Kučerová,et al.  Protective effect of selected flavonoids on in vitro daunorubicin‐induced cardiotoxicity , 2006, Phytotherapy research : PTR.

[28]  V. Labhasetwar,et al.  Targeted Drug Delivery in Cancer Therapy , 2005, Technology in cancer research & treatment.

[29]  M. Blank,et al.  Aptamers as tools for target validation. , 2005, Current opinion in chemical biology.

[30]  K. Jain.  Targeted Drug Delivery for Cancer , 2005 .

[31]  Bertrand Tavitian,et al.  Neutralizing Aptamers from Whole-Cell SELEX Inhibit the RET Receptor Tyrosine Kinase , 2005, PLoS biology.

[32]  Michael Zuker,et al.  Mfold web server for nucleic acid folding and hybridization prediction , 2003, Nucleic Acids Res..

[33]  A. Erdem,et al.  Interaction of the anticancer drug epirubicin with DNA , 2001 .

[34]  G. Johnson,et al.  Fat suppression in MR imaging: techniques and pitfalls. , 1999, Radiographics : a review publication of the Radiological Society of North America, Inc.

[35]  M. Meseguer,et al.  MUC1 and endometrial receptivity. , 1998, Molecular human reproduction.

[36]  S D Jayasena,et al.  Staining of cell surface human CD4 with 2'-F-pyrimidine-containing RNA aptamers for flow cytometry. , 1998, Nucleic acids research.